OriRx never prescribes medication. Every prescription is issued by a licensed MD or DO at MD Integrations β independently, based on clinical judgment alone.
MD Integrations is OriRx's prescriber partner. All prescriptions issued through OriRx are reviewed and issued by licensed physicians and qualified prescribers within the MD Integrations network.
MD Integrations providers operate with full clinical independence β OriRx does not direct, influence, or override any prescribing decision.
All prescribers are licensed MDs or DOs. Licenses are verified against state medical board records on a recurring basis and must be in good standing.
Prescribers follow established clinical guidelines for pharmacological treatment of obesity, applying standard eligibility criteria (BMI thresholds and weight-related comorbidities) used in clinical practice.
OriRx has no ability to override or direct a prescribing decision. A provider may decline to prescribe for any clinical reason without explanation or liability to OriRx.
Every intake receives a full clinical review β not a rubber stamp. Providers assess:
MD Integrations maintains active prescribing licenses in all 50 states. Licenses are maintained in the state where the patient is located at the time of service, as required by state law.
The initial review is asynchronous (store-and-forward). Certain states may require a synchronous (live) video or telephone visit before prescribing β your provider will advise if this applies to your state.
In compliance with California Business & Professions Code Β§ 680.5(e), Massachusetts Board of Registration in Medicine Policy 15-05 (2015), Rhode Island Board of Medical Licensure and Discipline Telemedicine Guidelines, and Vermont Board of Medical Practice Policy on Telemedicine, OriRx discloses the following: